Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea
· Delayed Price · Currency is KRW 15,650
+260 (1.69%)
May 14, 2025, 11:38 AM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Immunodiagnosis | 291.25B |
Log In |
Log In |
Log In |
Log In |
| Immunodiagnosis Growth | 159.02% |
Log In |
Log In |
Log In |
Log In |
| Biochemical Diagnosis - Blood Sugar Meter | 47.48B |
Log In |
Log In |
Log In |
Log In |
| Biochemical Diagnosis - Blood Sugar Meter Growth | 1.25% |
Log In |
Log In |
Log In |
Log In |
| Biochemical Diagnosis - Glycated Hemoglobin Meter | 9.87B |
Log In |
Log In |
Log In |
Log In |
| Biochemical Diagnosis - Glycated Hemoglobin Meter Growth | 18.09% |
Log In |
Log In |
Log In |
Log In |
| Molecular Diagnosis | 2.70B |
Log In |
Log In |
Log In |
Log In |
| Molecular Diagnosis Growth | -88.21% |
Log In |
Log In |
Log In |
Log In |
| Merchandise | 1.97B |
Log In |
Log In |
Log In |
Log In |
| Biochemical Diagnosis - Cholesterol/Liver Disease Meter | 1.96B |
Log In |
Log In |
Log In |
Log In |
| Biochemical Diagnosis - Cholesterol/Liver Disease Meter Growth | 36.43% |
Log In |
Log In |
Log In |
Log In |
| Other Product | 280.00M |
Log In |
Log In |
Log In |
Log In |
| Biochemical Diagnosis - Other | 55.00M |
Log In |
Log In |
Log In |
Log In |
| Other | 284.00M |
Log In |
Log In |
Log In |
Log In |
| Molecular Diagnostics Kit - Merchandised | - |
Log In |
Log In |
Log In |
Log In |
| Molecular Diagnostics Kit - Merchandised Growth | - |
Log In |
Log In |
Log In |
Log In |
| Others - Manufactured Products | - |
Log In |
Log In |
Log In |
Log In |
| Others - Manufactured Products Growth | - |
Log In |
Log In |
Log In |
Log In |
| Molecular Diagnostics Kit | - |
Log In |
Log In |
Log In |
Log In |
| Molecular Diagnostics Kit Growth | - |
Log In |
Log In |
Log In |
Log In |
| Other | 284.00M |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Other | 5.42B |
Log In |
Log In |
Log In |
Log In |
| Other Growth | 5.28% |
Log In |
Log In |
Log In |
Log In |
| North America | 292.71B |
Log In |
Log In |
Log In |
Log In |
| North America Growth | 646.37% |
Log In |
Log In |
Log In |
Log In |
| Europe | 20.56B |
Log In |
Log In |
Log In |
Log In |
| Europe Growth | -27.64% |
Log In |
Log In |
Log In |
Log In |
| South Korea | 17.80B |
Log In |
Log In |
Log In |
Log In |
| South Korea Growth | -80.08% |
Log In |
Log In |
Log In |
Log In |
| Asia | 11.12B |
Log In |
Log In |
Log In |
Log In |
| Asia Growth | -31.13% |
Log In |
Log In |
Log In |
Log In |
| South America | 8.25B |
Log In |
Log In |
Log In |
Log In |
| South America Growth | -47.27% |
Log In |
Log In |
Log In |
Log In |
| Other | 5.42B |
Log In |
Log In |
Log In |
Log In |
| Other Growth | 5.28% |
Log In |
Log In |
Log In |
Log In |